Full-Life Technologies logo — A Fully integrated global radiotherapeutics company with ope...

Full-Life Technologies

A Fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China.

Founded 2021 Belgium Belgium 64 employees Series B Total: $110.30M Biopharma, Health Care +1

General Information

Company Name Full-Life Technologies
Founded Year 2021
Location Belgium Belgium
Employees 64
Industries Biopharma, Health Care, Pharmaceutical
Funding Stage Series B
Business Model B2B, D2C
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Full-Life Technologies. To contact Full-Life Technologies, visit full-life.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Full-Life Technologies compare?

A PDF of Full-Life Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Full-Life Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Full-Life Technologies

Full-Life Technologies is a dynamic, fully integrated global radiopharmaceutical company with operations spanning Belgium, Germany, and China. Since its inception in 2021, the company aims to revolutionize the radiotherapeutics industry by owning the entire value chain from research and development to production and commercialization.

Driven by a team of adept entrepreneurs and scientists with extensive expertise in life sciences and clinical development, Full-Life Technologies addresses major challenges in the field through cutting-edge research focused on future therapies.

Headquartered in Belgium, the company recently secured a significant financial boost, closing a $47.30M Series B funding round on 03 January 2024. This investment was led by prominent investors such as Chengwei Capital, Sky9 Capital, and Sequoia Capital China, among others, signaling strong confidence in their growth trajectory.

Business keywords: Radiopharmaceuticals, Radiotherapeutics, Global Operations, Value Chain Integration, Cancer Therapy, Innovative Research, Clinical Development, Radioisotope Research, Production & Commercialization, Life Sciences Expertise, Entrepreneurial Team, Patient Impact, Radiopharmaceutical R&D

Services & Products

Radiopharmaceutical Discovery
Radiopharmaceutical Development
Manufacturing and Logistics of Radiopharmaceuticals
Global Operations in Radiotechnology

Target Customers

Oncologists Cancer Treatment Centers Pharmaceutical Researchers Healthcare Providers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Full $16.00M -
03 Jan 2024
Series B Full $47.30M 8
Chengwei Capital, Sky9 Capital +6
03 Jan 2024
Series A Full $37.00M 2
Yunion Health Investments, Sequoia Capital China
26 May 2022
Seed Round Full $10.00M 1
Chengwei Capital
21 Dec 2021

Full-Life Technologies Alternatives & Competitors

View All Alternatives
Full-Life Technologies vs
RayzeBio
RayzeBio United States

Targeted innovative radiopharmaceuticals for cancer

Acquired
258 employees
Biotechnology, Health Care
Full-Life Technologies vs

Discovering and developing novel radiotherapeutics for the treatment of cancer.

Series A
48 employees
Health Care, Health and Wellness
Full-Life Technologies vs

Delivering the promise of radiopharmaceuticals to patients.

Private Equity
661 employees
Biopharma, Biotechnology

FAQ About Full-Life Technologies

A Fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China.
Full-Life Technologies was founded in 2021.
Full-Life Technologies is headquartered in Belgium.
Full-Life Technologies operates in Biopharma, Health Care and Pharmaceutical. Its work centres on Radiopharmaceuticals, Radiotherapeutics, Global Operations and Value Chain Integration. Its customers include Oncologists, Cancer Treatment Centers and Pharmaceutical Researchers.
Full-Life Technologies has a B2B and D2C business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Full-Life Technologies has approximately 64 employees.
Full-Life Technologies has completed 4 funding rounds, raising a total of $110.30M. The latest funding stage is Series B.
Full-Life Technologies offers: Radiopharmaceutical Discovery, Radiopharmaceutical Development, Manufacturing and Logistics of Radiopharmaceuticals, Global Operations in Radiotechnology.
Top alternatives and competitors to Full-Life Technologies include RayzeBio, Radionetics Oncology, ITM Isotope Technologies Munich SE, ARTBIO, Adaptimmune. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Full-Life Technologies and RayzeBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Full-Life Technologies, https://bouncewatch.com/company/full-life-technologies, updated 23 February 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes